Logo wahanariau.com
  2. Adagene

Adagene

Index
Globenewswire

Adagene to Present at Leerink’s Global Healthcare Conference 2025

Kamis, 06 Maret 2025 - 20:30:00 Wib
Globenewswire

Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer

Jumat, 28 Februari 2025 - 00:20:02 Wib
Globenewswire

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

Senin, 27 Januari 2025 - 19:30:00 Wib
Globenewswire

Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

Rabu, 22 Januari 2025 - 14:35:27 Wib
Globenewswire

Adagene to Host Virtual KOL Event to Discuss Anti-CTLA-4 SAFEbody® ADG126 in Advanced/Metastatic Microsatellite-Stable (MSS) Colorectal Cancer (CRC) on January 25, 2025

Selasa, 14 Januari 2025 - 20:30:00 Wib
Globenewswire

Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Soc

Kamis, 07 November 2024 - 22:30:00 Wib
Globenewswire

Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Rabu, 09 Oktober 2024 - 17:30:00 Wib
Globenewswire

Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

Senin, 16 September 2024 - 14:30:00 Wib
Globenewswire

Adagene to Participate in Investor Conferences in September

Kamis, 29 Agustus 2024 - 18:30:00 Wib
Globenewswire

Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update

Jumat, 26 Juli 2024 - 09:10:07 Wib
Globenewswire

Adagene Announces Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at Upcoming European Society for Medical Oncology (ESMO) Congress in September

Jumat, 12 Juli 2024 - 18:30:00 Wib